DV
Dividend Vision

CUPR — Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)

Total return is -90.9% over the past 1.3 years, 141.0 points behind SPY at 50.1%. Its deepest 1-year drawdown was 97.4%.

Cuprina Holdings (Cayman) Limited is a biomedical and biotechnology company focused on developing and commercializing products for chronic wound management, including sterile blowfly larvae bio-dressing products under the MEDIFLY brand, collagen-based dressings derived from bullfrog collagen, and medical leech products for wound treatment. The company does not currently distribute dividends. This security appeals primarily to growth-oriented investors interested in specialized medical device and biotechnology development.

CUPR key facts

Asset type
Stock
Asset class
Equity
Inception date
04/10/2025
Last close
$3.01
Market cap
$10,644,563
Average volume
33500.0
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.41